Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials
C. H. Brahe*, C. Dehlendorff, M. Østergaard, J. S. Johansen, L. M. Ørnbjerg, K. Hørslev-Petersen, K. Stengaard-Pedersen, P. Junker, T. Ellingsen, H. Lindegaard, I. Hansen, T. Lottenburger, S. Jacobsen, A. G. Jurik, M. L. Hetland
Dive into the research topics of 'Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials'. Together they form a unique fingerprint.